Spyre Therapeutics Inc (SYRE)

Net Change in Cash

$64.82M

Quarterly · Period ending: · USD

SYRE logo

SYRE Net Change in Cash

Latest reported$64.82M
SYRE Quarterly Net Change in Cash (-$1.37M → $64.82M)
High-resolution chart · PNG

SYRE net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
64,822,000
11,464,000
20,824,000
-16,762,000
33,166,000
-40,930,000
17,843,000
26,115,000
-182,408,000
38,656,000
97,316,000
-144,776,000
200,122,000
137,000
-4,102,000
1,244,000
22,809,000
-515,000
-9,522,000
-10,109,000
-45,465,000
-9,861,000
36,214,000
-11,490,000
53,119,000
-6,659,000
-5,292,000
-885,000
-58,715,000
63,184,000
7,929,000
-6,047,000
9,819,000
-2,057,000
-345,000
-13,772,000
10,133,000
-30,947,000
-1,796,000
-21,084,000
46,612,000
-5,278,000
-1,546,000
-8,241,000
-4,710,000
41,175,000
-3,086,000
3,700,000
-1,222,000
-1,373,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.